News
Serum Institute of India Seeks DCGI's Approval for Market Authorisation of Its COVID-19 ... - Latest Tweet by PTI News
The latest Tweet by PTI News states, 'Serum Institute of India seeks DCGI's approval for market authorisation of its COVID-19 vaccine Covovax as booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin: Official sources'
Serum Institute of India seeks DCGI's approval for market authorisation of its COVID-19 vaccine Covovax as booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin: Official sources— Press Trust of India (@PTI_News) December 22, 2022
(The above story first appeared on LatestLY on Dec 22, 2022 04:20 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
